Search Our Site
Latest News
-
The ALS Association Announces New Research Grants
The ALS Association is proud to announce seven new research grants that will allow scientists to study several of topics pertinent to The Association's TREAT ALS Research Portfolio.
-
Drug Company Working Group Meeting Attracts Professionals from Academia and Industry to Discuss Therapeutic Opportunities for ALS
The ALS Association brought together an overflow crowd of individuals with the common purpose of finding new ALS treatments at The American Academy of Neurology Annual Meeting.
-
Request for Proposals - Clinical Management and Research
Two open calls for proposals: Clinical Research Pilot Study and Clinical Management Grants. Deadline for brief study outline is May 28, 2012.
-
Cytokinetics Announces Encouraging Results from CK-2017357 Phase II Clinical Trials
As reported at the 64th annual meeting of the American Academy of Neurology, Cytokinetics' drug CK-2017357 has been shown to be safe and well-tolerated at different dosage levels when used alone or in combination with riluzole.
-
2012 Sheila Essey Award Recipient Recognized at American Academy of Neurology Conference
A clinician scientist with a strong background in molecular cell biology received the prestigious award for ALS research on April 24.
Community of Hope
Online Funds to Honor and Remember.
Share your story or find a fund...join the community now and make a difference!
OUR MISSION: Leading the fight to treat and cure ALS through global research and nationwide advocacy while also empowering people with Lou Gehrig's Disease and their families to live fuller lives by providing them with compassionate care and support.
The ALS Association - 1275 K Street NW - Suite 1050 - Washington, DC 20005
All content and works posted on this website are owned and copyrighted by The ALS Association. ©2010
